Martin Charles Faulkes, Director at VOLITIONRX LTD (VNRX), bought 50,000 shares at $3.94 ($197K) on 2019-08-15, disclosed to the SEC on 2019-08-16.
Open-market purchase of $197k VNRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| VNRX | SELL | 2020-09-10 | $209K | — | Filing → |
| VNRX | BUY | 2019-08-28 | $38K | — | Filing → |
| VNRX | BUY | 2019-06-13 | $461K | — | Filing → |